← Back to Search

Other

Walnuts for Immune Response (walnutimmune Trial)

N/A
Recruiting
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not taking medication or supplements that affect immunity
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights

walnutimmune Trial Summary

This trial explores if eating walnuts can help boost immunity in older adults who are overweight.

Who is the study for?
This study is for older men and postmenopausal women aged 55-75 with a BMI of 25-32. Participants should be able to travel to Loma Linda University and not be on medications or supplements that affect immunity. Those with immune diseases, recent vaccinations, nut allergies, high nut consumption, or exposure to certain drugs can't join.Check my eligibility
What is being tested?
The trial aims to see if eating walnuts improves the immune system in older adults who are overweight. It compares their usual diet with one including walnuts over time to observe changes in how they respond to respiratory infections like the common cold.See study design
What are the potential side effects?
Since this trial involves adding walnuts to the diet, potential side effects may include digestive discomfort or allergic reactions for those sensitive to nuts.

walnutimmune Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not on any immune-affecting drugs or supplements.

walnutimmune Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in concentration of Calprotectin in feces
Changes in concentration of Immunoglobulin A in feces
Changes in concentration of small chain fatty in feces
+5 more
Secondary outcome measures
changes in upper respiratory infection questionnaire score

walnutimmune Trial Design

2Treatment groups
Active Control
Group I: walnut groupActive Control1 Intervention
walnut group will receive 15% of their total energy as walnuts
Group II: control groupActive Control1 Intervention
continue with habitual diet and abstain from eating walnuts

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,930 Total Patients Enrolled

Media Library

Walnuts (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05915390 — N/A
Immune Response Research Study Groups: walnut group, control group
Immune Response Clinical Trial 2023: Walnuts Highlights & Side Effects. Trial Name: NCT05915390 — N/A
Walnuts (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05915390 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join the research trial?

"All prospective members of this medical trial must have a healthy immune system and be aged between 55 to 75. Altogether, 54 people need to be enrolled in the study."

Answered by AI

Are there still opportunities for people to become participants in this clinical trial?

"According to the clinicaltrials.gov website, this medical experiment is no longer recruiting participants as of June 21st 2023. The initial posting for this trial was on June 1st 2023. However, there are 92 other studies actively looking to enroll patients at present time."

Answered by AI

Is this research open to individuals aged over 55?

"This medical study is calling on elderly individuals aged 55 to 75 years old."

Answered by AI
~5 spots leftby Jun 2024